18F –FDG PET/BT İLE NORMAL SÜRRENAL BEZ AKTİVİTE TUTULUMLARININ DEĞERLENDİRİLMESİ
Öz
Anahtar Kelimeler
Kaynakça
- 1. Pelosi E, Messa C, Sironi S, et al. value of integrated PET/CT for lesion localisation in cancer patients: a comparative study. Eur J Nucl Med Mol Imaging 2004;31:932-939.
- 2. Lin EC, Alavi A: PET ve PET/BT Klinik Kılavuzu. 60.Baskı. Habitat yayınları; 2011: 114-115.
- 3. Kenney P, Lee J. The adrenals. In: Heiken J, ed. Computed Body Tomography with MRI Correlation. 3rd ed. Philadelphia: PA: Lippincott-Raven; 1999:1171–1208.
- 4. Bagheri B, Maurer AH, Cone L, Doss M, Adler L. Characterization of the Normal Adrenal Gland with 18F-FDG PET/CT. J Nucl Med 2004;45:1340-1343.
- 5. Yun M, Kim W, Alnafisi N, Lacorte L, Jang S, Alavi A. 18F-FDG PET in characterizing adrenal lesions detected on CT or MRI. J Nucl Med.2001;42:1795–1799.
- 6. Maurea S, Klain M, Mainolfi C, Zivi-ello M, Salvatore M. The diagnostic role of radionuclide imaging in evaluation ofpatients with nonhypersecreting adrenal masses. J Nucl Med. 2001;42:884–892.
- 7. Shulkin BL, Thompson NW, Shapiro B, Francis IR, Sisson JC. Pheochromocytomas: imaging with 2-(fluorine-18)fluoro-2-deoxy-D-glucose PET. Radiology. 1999; 212: 35–41.
- 8. Elaini AB, et al. Improved detection and characterization of adrenal disease with PET/CT. Radiographics 2007; 27:755-767.
Ayrıntılar
Birincil Dil
Türkçe
Konular
Nükleer Tıp
Bölüm
Klinik Araştırma
Yazarlar
Mutlay Keskin
*
Türkiye
Yayımlanma Tarihi
22 Mart 2015
Gönderilme Tarihi
19 Mart 2015
Kabul Tarihi
19 Mart 2015
Yayımlandığı Sayı
Yıl 2015 Cilt: 7 Sayı: 1